Get started
Award

N01 CN055154

Subfield: Epidemiology
Field: Medicine
Funded outputs count: 20
Funder award ID: N01 CN055154
OpenAlex ID: G1051767775
Different human papillomavirus types share early natural history transitions in immunocompetent women
2022 · Sally N. Adebamowo, Brian Befano, et al. · International Journal of Cancer · 17
Seroprevalence of 8 Oncogenic Human Papillomavirus Genotypes and Acquired Immunity Against Reinfection
2014 · L. Wilson, M. Pawlita, et al. · The Journal of Infectious Diseases · 43
PDF
Risk of Precancer Determined by HPV Genotype Combinations in Women with Minor Cytologic Abnormalities
2013 · Julia C. Gage, Mark Schiffman, et al. · Cancer Epidemiology Biomarkers & Prevention · 32
Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS‐LSIL Triage Study
2013 · Lauren E. Wilson, Michael Pawlita, et al. · International Journal of Cancer · 20
PDF
Evaluation of Any or Type-Specific Persistence of High-Risk Human Papillomavirus for Detecting Cervical Precancer
2011 · Morgan A. Marks, Philip E. Castle, et al. · Journal of Clinical Microbiology · 24
PDF
Policy Implications of Adjusting Randomized Trial Data for Economic Evaluations: A Demonstration from the ASCUS-LSIL Triage Study
2011 · Nicole G. Campos, Philip E. Castle, et al. · Medical Decision Making · 5
The Clinical Meaning of a Cervical Intraepithelial Neoplasia Grade 1 Biopsy
2011 · Philip E. Castle, Julia C. Gage, et al. · Obstetrics and Gynecology · 54
Evaluation of a New DNA Test for Detection of Carcinogenic Human Papillomavirus
2011 · Philip E. Castle, Erin C. Gutierrez, et al. · Journal of Clinical Microbiology · 33
Comparison of Measurements of Human Papillomavirus Persistence for Postcolposcopic Surveillance for Cervical Precancerous Lesions
2010 · Julia C. Gage, Mark Schiffman, et al. · Cancer Epidemiology Biomarkers & Prevention · 26
PDF
Human Papillomavirus Genotypes in Cervical Intraepithelial Neoplasia Grade 3
2010 · Philip E. Castle, Mark Schiffman, et al. · Cancer Epidemiology Biomarkers & Prevention · 51
PDF
Impact of Improved Classification on the Association of Human Papillomavirus With Cervical Precancer
2009 · P. E. Castle, M. Schiffman, et al. · American Journal of Epidemiology · 28
PDF
A Study of Amplicor Human Papillomavirus DNA Detection in the Atypical Squamous Cells of Undetermined Significance–Low-Grade Squamous Intraepithelial Lesion Triage Study
2009 · Nicolas Wentzensen, Patti E. Gravitt, et al. · Cancer Epidemiology Biomarkers & Prevention · 23
PDF
Influence of Loop Electrosurgical Excision Procedure on Subsequent Acquisition of New Human Papillomavirus Infections
2009 · Philip E. Castle, Aimée R. Kreimer, et al. · The Journal of Infectious Diseases · 9
Detection of Precancerous Cervical Lesions Is Differential by Human Papillomavirus Type
2009 · Mahboobeh Safaeian, Mark Schiffman, et al. · Cancer Research · 62
PDF
Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia–Grade 2
2009 · Philip E. Castle, Mark Schiffman, et al. · Obstetrics and Gynecology · 388
Factors Influencing Histologic Confirmation of High-Grade Squamous Intraepithelial Lesion Cytology
2008 · Philip E. Castle, J Thomas Cox, et al. · Obstetrics and Gynecology · 21
Human Papillomavirus Genotype Specificity of Hybrid Capture 2
2008 · Philip E. Castle, Diane Solomon, et al. · Journal of Clinical Microbiology · 176
A Comparison of Linear Array and Hybrid Capture 2 for Detection of Carcinogenic Human Papillomavirus and Cervical Precancer in ASCUS-LSIL Triage Study
2008 · Patti E. Gravitt, Mark Schiffman, et al. · Cancer Epidemiology Biomarkers & Prevention · 68
PDF
Comparison of Linear Array and Line Blot Assay for Detection of Human Papillomavirus and Diagnosis of Cervical Precancer and Cancer in the Atypical Squamous Cell of Undetermined Significance and Low-Grade Squamous Intraepithelial Lesion Triage Study
2007 · Philip E. Castle, Patti E. Gravitt, et al. · Journal of Clinical Microbiology · 98
Performance of cytology and human papillomavirus testing in relation to the menstrual cycle
2006 · for the ALTS Group, M E Sherman, et al. · British Journal of Cancer · 21
PDF